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Conotoxin, a thirteen residue neurotoxic peptide, is demonstrated, by circular dichroism measurements, to 
possess a high contentof a-helix. The location of this helix in the sequence is severely limited by the structur- 
al preferences of individual amino acids and by the positioning of the two cystine links. Comparisons are 
made between the reactive site of elapidae snake venom postsynaptic neurotoxins and the surface of the 
conotoxin molecule. 
Conidae Conotoxin Neurotoxicity 
1. INTRODUCTION 
The harpoon-like radula’ teeth of Conidae, a 
family of marine gastropods, are used to im- 
mobilise prey organisms, in particular fish [l-3]. 
Kohn et al. [4] demonstrated that a major action of 
the venom was interference with neuromuscular 
transmission, a finding subsequently supported by 
the work of Endean and Rudkin [5]. Isolation and 
partial characterisation of the components respon- 
sible for this activity were reported by Spence et al. 
[6] and Cruz et al. [7] both of whom purified pep- 
tide components from Conus geographus venom. 
The primary sequences of three homologous con- 
otoxins were presented in 1981 [8]. These peptides 
contain between 13 and 15 amino acids including 
4 half cystines (table 1). The assignment of the two 
cystine links has been achieved by chemical syn- 
thesis for 4 homologous conotoxins [9,10]. 
Synthetic conotoxins [9-121 possess full 
biological activity and hence the information for 
the correct folding of the peptide chain is present 
in the amino acid sequence. Thus conotoxins 
would appear to be suitable candidates for secon- 
dary structure prediction. 
Similar studies with other disulphide-rich venom 
toxins have been remarkably successful, for in- 
Circular dichroism Secondary structure 
stance apamin [ 13,141, elapidae postsynaptically 
acting toxins [ 15,161 and phospholipase A2 
molecules [171. This paper proposes a structure for 
the conotoxins on the basis of both circular 
dichroism (CD) measurements and an analysis of 
secondary structural tendencies. 
2. METHODS 
Circular dichroism measurements were made on 
a Jasco J4OCS instrument, using 0.02- and l-cm 
cells at 25°C. Toxin concentrations were deter- 
mined using an estimated cm (280 nm) of 115. 
Molar ellipticities per residue are reported. 
A modification [14] of Chou and Fasman’s 
original method of secondary structure prediction 
[18], which uses the product of the parameters 
rather than the arithmetic mean to detect structural 
tendencies, was adopted. The parameters deter- 
mined by Levitt [19] were used. 
3. RESULTS AND DISCUSSION 
The CD spectrum of conotoxin GI (1.75 x 
10m4 M) in Tris-HCl (20 mM, pH 7.4) (fig.1) is 
consistent with a high a-helical content and is 
remarkably similar to that of apamin [20], which, 
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Fig.1. CD spectra of conotoxin Gl. (-) Tris-HCl 
(20 mM, pH 7.4); (---) HzO-HCl (pH 1.0); (-----) 
90% aqueous trifluoroethanol. 185-250 nm (0.02 cm 
cell); 250-320 nm (1 cm cell). 
despite possessing two cystine links, is a-helical 
[13,14,20,21]. The negative cotton effect for cono- 
toxin in the region 200-220 nm is in agreement 
with previous CD studies [lo]. The near UV region 
is dominated by contributions from the cystine and 
tyrosine functions. The dichroism at 280 nm is of 
similar magnitude and sign to that of apamin [22] 
and oxytocin [23], the former peptide possessing 
two cystine functions and the latter one cystine and 
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one tyrosine. By comparison with a series of com- 
puted spectra corresponding to a polypeptide chain 
in varying percentages of a-helix and random coil 
[24], it can be estimated that approx. 50% of cono- 
toxin GI possesses a-helical conformation. Like 
apamin, the conformation of conotoxin remains 
relatively constant over a wide pH range (1 .O-9.0), 
and in the presence of 90% trifluoroethanol 
(fig. 1). This stability is probably dependent on the 
two disulphide links and hydrogen bonding be- 
tween the backbone amide groups. 
To locate the most probable site of the helical 
region in conotoxin, a secondary structure predic- 
tion study was undertaken for the 4 homologous 
toxins [23] (fig.2). Although some appreciable LY- 
helical tendency is present in the N-termini of the 
4 sequences, in particular for conotoxin GII, the 
conserved proline- renders such a structure im- 
probable. A consistent a-helical prediction was ob- 
tained for the region 6-10 with an average (Pcu) 
value of 1.03 for the 4 peptides. Although this 
value is not high, it is appreciably greater than the 
corresponding (Pfl) value, 0.82. As pointed out by 
Levitt [19], this average (Pa) corresponds to a 
value where only 40% of the residues are found ex- 
perimentally to be a-helical. However, the average 
I 
G R $ L: H P A $ G K N Y S C 
E C C N 
E C C N 
E C C H 
0.81 0.72 0.97 0.97 0.49 
0.80 0.72 0.72 0.45 
0.80 0.72 0.72 0.45 
1.08 0.97 0.97 0.49 
Fig.2. Conotoxin sequences and a-helical predictions [15,191. r5cr, product of Pa values [19] of 5 adjacent residues. 
(Pa), average of Pcu values [18]. Sequences taken from McIntosh et al. [25]. 
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P A C G R H Y S C 
P A C G R H Y S C G K 
P A C G K H F S C 
0.47 0.84 0.47 0.35 0.68 - - - - 
CPU> = 1.00 4 . 
0.48 0.94 0.65 0.48 0.95 - - - - 
<Pa> = 1.03 4 c 
0.48 0.94 0.65 0.48 0.95 0.55 0.53 - - - - 
<Pa> = 1.03 4 l 
0.47 1.13 0.94 0.70 1.38 
<Pa> = 1.07 c 
Mean <Pc~>~_~~ = 1.03 
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(Pfl) value corresponds to a value where only 20% 
of the residues are found to possess a P-extended 
conformation. Significantly, if the parameters 
derived by Geisow and Roberts for a-helical rich 
proteins [26] are used, then the (Pa) values in- 
crease to 1.08. When this segment adopts an U- 
helical conformation, it is possible to form the 2-7 
and 3-13 disulphide links. Indeed, systematic 
variation of the Ramachandran angles of the re- 
maining residues of the conotoxin GI sequence 
generated a structure which is consistent with CD 
spectral properties of conotoxin (fig.3). This struc- 
ture, which is currently being subjected to energy 
minimisation studies, offers an explanation for the 
conserved glycine-8, as the N-terminal peptide 
folds back along the surface of the a-helix adjacent 
to residue 8 (fig.3B). Recently, it has been 
demonstrated that the synthetic alanyl-8 isotoxin 
possesses a marked reduction in activity [27]. Thus 
glycine, normally a strong helix breaker, cannot be 
replaced without distorting the proposed native 
conformation of the toxin. In a similar fashion, 
substitution of proline-5, by glycine, yields a non- 
toxic peptide [27]. The proline, which is positioned 
at the N-terminal end of the a-helix (fig.3B), is 
probably essential for the close orientation of cys- 
teine residues 3 and 13, during the folding process. 
Significantly, proline residues are positioned in 
analogous positions in the bee venom toxins 
apamin, mast cell degranulating peptide and ter- 
tiapin [28]. 
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It has been established that conotoxins GI and 
GII compete with the binding of cy- 
[1251]bungarotoxin to the acetylcholine receptor 
present on mouse diaphragm end plates [29], and 
are at least lo-times more potent than the well 
characterised alkaloid antagonist d-tubocurarine. 
An extensive structure-activity study has been 
reported for the elapidae neurotoxins, including LY- 
bungarotoxin, and a reactive site of these 
molecules has been identified [16]. It is now possi- 
ble to compare the tentative 3D structure of the 
conotoxins with this reactive site [ll]. In the 4 
conotoxins there are two positive centres at posi- 
tions 1 and 9 separated by approx. 14-15 A, a 
similar distance to that between two of the con- 
served basic residues in the elapidae toxins, which 
are believed to be essential for interaction with the 
nicotinic receptor [ 15,161. Furthermore, between 
the two basic residues on conotoxins GI and GII 
Fig.3. Structure of conotoxin Gl. (A) Ramachandran 
angles of the refined structure built with Nicholson 
models. (B) Schematic representation f the structure, 
indicating the relative positioning of the disulphide 
bonds with respect to the a-helix. The proposed reactive 
site consists of residues 1, 9, 10 and 11. 
are two aromatic side chains (fig.3B). Precisely the 
same arrangement occurs with the elapidae toxins 
[ 161 and dicationic alkaloid nicotinic antagonists 
[30,31]. Thus the interactive region of the cono- 
toxins is probably centred on residues 1, 9, 10 and 
11; significantly, replacement of L-tyrosine-1 1 
with D-tyrosine leads to total loss of activity [27]. 
Presumably glutamate-l is not essential for activity 
as glycylarginine replaces this residue in conotoxin 
Ml. Although histidine-10 exchanges for 
asparagine-4 in MI, histidine-4 is orientated to the 
same side of the molecule as tyrosine-1 1. As cono- 
183 
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toxins are amenable to chemical synthesis, 
specifically designed isotoxins could prove useful 
in the further characterisation of the 3D structure 
of the nicotinic receptor. 
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